Novavax, Inc. (NVAX)
6.67
-0.11
(-1.62%)
USD |
NASDAQ |
Dec 09, 16:00
6.67
0.00 (0.00%)
After-Hours: 20:00
Novavax Market Cap: 1.084B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 144.08B |
| Moderna, Inc. | 11.05B |
| Merck & Co., Inc. | 240.57B |
| Sangamo Therapeutics, Inc. | 168.11M |
| Arcturus Therapeutics Holdings, Inc. | 204.43M |
Market Cap Related Metrics
| PE Ratio | 3.771 |
| PS Ratio | 1.061 |
| Price | 6.67 |
| Earnings Yield | 26.52% |
| Operating PE Ratio | 2.711 |
| Normalized PE Ratio | 2.824 |